logo
Book a meeting
SciNeuro Pharmaceuticals

Sci Neuro Pharmaceuticals

Biotechnology, 8 Clarke Dr, Rockville, Maryland, 08512, United States, 11-50 Employees

scineuro.com

  • LinkedIn

Who is SCINEURO PHARMACEUTICALS

SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has ...

Read More

lock icon Get Full Access
map
  • 8 Clarke Dr, Rockville, Maryland, 08512, United States Headquarters: 8 Clarke Dr, Rockville, Maryland, 08512, United States
  • 2020 Date Founded: 2020
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 456110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SCINEURO PHARMACEUTICALS

SciNeuro Pharmaceuticals Org Chart and Mapping

Employees
Marybeth Curtis

Marybeth Curtis

Senior Scientist

Diana Eng

Diana Eng

Senior Associate Scientist

Zusheng Li

Zusheng Li

Associate Director, Antibody Discovery & Development

Yuka Martens

Yuka Martens

Director, Head of Biology

See Full Org Chart arrow
email-formate-icon
View Email Formats for SciNeuro Pharmaceuticals
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding SciNeuro Pharmaceuticals

Answer: SciNeuro Pharmaceuticals's headquarters are located at 8 Clarke Dr, Rockville, Maryland, 08512, United States

Answer: SciNeuro Pharmaceuticals's official website is https://scineuro.com

Answer: SciNeuro Pharmaceuticals's revenue is Under $1 Million

Answer: SciNeuro Pharmaceuticals's SIC: 2834

Answer: SciNeuro Pharmaceuticals's NAICS: 456110

Answer: SciNeuro Pharmaceuticals has 11-50 employees

Answer: SciNeuro Pharmaceuticals is in Biotechnology

Answer: SciNeuro Pharmaceuticals contact info: Phone number: Website: https://scineuro.com

Answer: SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration neurovascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimers disease, Parkinsons disease, and other devastating CNS diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access